Ginkgo Bioworks acquires Proof Diagnostics to boost cell programming and biosecurity capabilities
Ginkgo Bioworks, a leader in cell programming and biosecurity, announced its acquisition of Proof Diagnostics, a trailblazer in life sciences tools, diagnostics, and computational discovery. Specializing in genome engineering tools for therapeutic and diagnostic applications, Proof Diagnostics has been at the forefront of developing a smart, portable system for detecting infectious diseases and other medical […]